SI-BONE, Inc.SIBNEarnings & Financial Report
Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.
SIBN Q4 FY2025 Key Financial Metrics
Revenue
$56.3M
Gross Profit
$44.5M
Operating Profit
$-2.5M
Net Profit
$-1.6M
Gross Margin
79.0%
Operating Margin
-4.4%
Net Margin
-2.9%
YoY Growth
15.0%
EPS
$-0.04
SI-BONE, Inc. Q4 FY2025 Financial Summary
SI-BONE, Inc. reported revenue of $56.3M (up 15.0% YoY) for Q4 FY2025, with a net profit of $-1.6M (up 63.4% YoY) (-2.9% margin). Cost of goods sold was $11.8M, operating expenses totaled $47.0M.
Key Financial Metrics
| Total Revenue | $56.3M |
|---|---|
| Net Profit | $-1.6M |
| Gross Margin | 79.0% |
| Operating Margin | -4.4% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
SI-BONE, Inc. Q4 FY2025 revenue of $56.3M breaks down across 2 segments, led by US at $53.5M (94.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| US | $53.5M | 94.9% |
| Non Us | $2.9M | 5.1% |
SI-BONE, Inc. Revenue by Segment — Quarterly Trend
SI-BONE, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as US and Non Us) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| US | $53.5M | $46.4M | $46.4M | $44.8M |
| Non Us | $2.9M | $2.3M | $2.2M | $2.5M |
SI-BONE, Inc. Annual Revenue by Year
SI-BONE, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $200.9M).
SI-BONE, Inc. Quarterly Revenue & Net Profit History
SI-BONE, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $56.3M | +15.0% | $-1.6M | -2.9% |
| Q3 FY2025 | $48.7M | +20.6% | $-4.6M | -9.4% |
| Q2 FY2025 | $48.6M | +21.7% | $-6.2M | -12.7% |
| Q1 FY2025 | $47.3M | +24.9% | $-6.5M | -13.8% |
| Q4 FY2024 | $49.0M | +26.1% | $-4.5M | -9.2% |
| Q3 FY2024 | $40.3M | +18.6% | $-6.6M | -16.3% |
| Q2 FY2024 | $40.0M | +20.0% | $-8.9M | -22.4% |
| Q1 FY2024 | $37.9M | +15.8% | $-10.9M | -28.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.9M | $40.0M | $40.3M | $49.0M | $47.3M | $48.6M | $48.7M | $56.3M |
| YoY Growth | 15.8% | 20.0% | 18.6% | 26.1% | 24.9% | 21.7% | 20.6% | 15.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $223.7M | $223.8M | $227.0M | $230.4M | $227.3M | $230.9M | $234.3M | $238.6M |
| Liabilities | $58.2M | $59.1M | $62.0M | $63.5M | $60.0M | $60.6M | $62.1M | $61.0M |
| Equity | $165.5M | $164.7M | $165.0M | $167.0M | $167.3M | $170.3M | $172.1M | $177.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-7.6M | $-6.3M | $302000 | $1.2M | $-4.9M | $173000 | $2.3M | $1.7M |